Identification of the nasopharyngeal carriage of neisseria meningitidis by 16S rRNA gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019−2020)
Artículo
Open/ Download
Access note
Acceso abierto
Publication date
2022Metadata
Show full item record
Cómo citar
Macias Mendoza, Marlon
Cómo citar
Identification of the nasopharyngeal carriage of neisseria meningitidis by 16S rRNA gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019−2020)
Author
Abstract
The bacterium Neisseria meningitidis, a strictly human pathogen, can cause meningitis, meningococcemia, sepsis, and death; repeatedly it scause outbreaks around the world. The frequency of asymptomatic carriage is often high in adolescents and young adults, increasing the invasive meningococcal disease risk and likelihood of transmission. However, detailed analyses of meningococcal carriage in this population in Colombia, particularly in coastal areas, are lacking. In this study, the prevalence and characteristics of Neisseria meningitidis carriage were evaluated in asymptomatic adolescents and young adults (11-25 years old) in Cartagena, Colombia. Oropharynx samples were collected from participants between August and December 2019. The phenotypic identification of bacteria was performed by conventional methods and biochemical testing. Molecular identification to the species level was performed by 16S rRNA gene sequencing. In total, 12 of 648 samples were positive for Neisseria meningitidis by 16S rRNA sequencing, indicating a prevalence of 1.9%. Isolates were classified into four invasive serogroups (A, B, C, and W) by a comparative sequence analysis of the ribosomal gene. Despite the occurrence of meningococcal disease in Cartagena city in the last several years, the frequency of oropharyngeal carriage in adolescents and young adults was low. Serogroup A had not been previously reported in nasopharyngeal samples in Colombia. This is the first report of Neisseria meningitidis on the Colombian Caribbean coast based on 16S rRNA sequencing and is expected to guide the development of vaccination and follow-up strategies.
Patrocinador
Sanofi Pasteur MEN52
Indexation
Artículo de publícación WoS
Quote Item
braz j infect dis. 2022;26(1):102330
Collections
The following license files are associated with this item: